[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CR9269A - Vacunas orales para peces - Google Patents

Vacunas orales para peces

Info

Publication number
CR9269A
CR9269A CR9269A CR9269A CR9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A
Authority
CR
Costa Rica
Prior art keywords
fish
production
complexes
protein complex
vaccines
Prior art date
Application number
CR9269A
Other languages
English (en)
Inventor
Elisabeth Antonius Florack Dionisius
Jan Bosch Hendrik
Original Assignee
Wageningen Business Generator B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wageningen Business Generator B V filed Critical Wageningen Business Generator B V
Publication of CR9269A publication Critical patent/CR9269A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion tiene que ver con el desarrollo, composicion y produccion de vacunas para las mucosas loralesi de los peces. De forma mas especifica, la invencion es relativa a complejos proteinicos que transportan antigenos a y a traves de las superficies mucosas de los peces para inducir una respuesta inmunitaria, y a la produccion de dichos complejos en una celula hospedadora, preferiblemente vegetal. Se provee el uso de un complejo proteinico que contiene un antigeno de interes fusionado con la subunidad B de la toxina del colera Vibrio cho]erae (CT-B) o de la enterotoxina termolabil Escherichia coli (LT-B) para la fabricacion de una vacuna oral para peces. Se provee tambien alimento para peces que contiene un complejo proteinico de la invencion.
CR9269A 2005-01-26 2007-07-20 Vacunas orales para peces CR9269A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05075203A EP1685848A1 (en) 2005-01-26 2005-01-26 Oral vaccines for fish

Publications (1)

Publication Number Publication Date
CR9269A true CR9269A (es) 2007-11-23

Family

ID=34938018

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9269A CR9269A (es) 2005-01-26 2007-07-20 Vacunas orales para peces

Country Status (8)

Country Link
US (1) US20080274126A1 (es)
EP (2) EP1685848A1 (es)
JP (1) JP2008531478A (es)
AU (1) AU2006209101A1 (es)
CA (1) CA2595913A1 (es)
CR (1) CR9269A (es)
NO (1) NO20074090L (es)
WO (1) WO2006080842A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120088819A1 (en) * 2008-10-31 2012-04-12 Makoto Inoue Method for enhancing expression of recombinant protein
WO2010109874A1 (ja) 2009-03-26 2010-09-30 国立大学法人東京海洋大学 コイヘルペスウイルス特異的抗体及びその抗原
CL2009001197A1 (es) * 2009-05-15 2009-08-21 Farm En Aquacultura Veterinaria Fav S A Composicion farmaceutica veterinaria que contiene la variedad chilena del virus de la anemia infecciosa del salmon, marcadores proteicos y excipientes farmaceuticasmente aceptables; procedimiento de obtencion del virus; uso de la composicion para preparar una vacuna destinada a la prevencion del virus isa.
US8999319B2 (en) * 2010-06-09 2015-04-07 Mississippi State University Oral vaccination of fish with live attenuated Edwardsiella ictaluri vaccines
US9345760B2 (en) 2011-09-09 2016-05-24 Advanced Bionutrition Corporation IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
CN107056898A (zh) * 2017-02-13 2017-08-18 中国水产科学研究院珠江水产研究所 鲤疱疹病毒3型1301株orf136基因重组表达蛋白、抗体及其应用
CN110747219A (zh) * 2019-11-29 2020-02-04 浙江省淡水水产研究所 一种可添加于饲料中的鲤鱼鲤春病毒血症口服疫苗
CN113951183B (zh) * 2021-11-19 2022-10-25 莱州明波水产有限公司 黄带拟鲹亲鱼培育方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354555A (en) * 1985-04-10 1994-10-11 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine to control the viral infection of fish
GB9112553D0 (en) * 1991-06-11 1991-07-31 Wellcome Found Fusion proteins
EP0793717B1 (en) * 1994-10-24 2005-01-26 The Texas A & M University System Oral immunization with transgenic plants
WO1999018225A1 (en) * 1997-10-07 1999-04-15 Loma Linda University Expression of cholera toxin b subunit in transgenic plants and efficacy thereof in oral vaccines
CA2398462A1 (en) * 2000-01-27 2001-08-02 William H. R. Langridge Transgenic plant-based vaccines
EP1522585A1 (en) * 2003-10-09 2005-04-13 Plant Research International B.V. Chimeric carrier molecules for the production of mucosal vaccines

Also Published As

Publication number Publication date
JP2008531478A (ja) 2008-08-14
NO20074090L (no) 2007-10-24
US20080274126A1 (en) 2008-11-06
AU2006209101A1 (en) 2006-08-03
EP1685848A1 (en) 2006-08-02
EP1850868A2 (en) 2007-11-07
CA2595913A1 (en) 2006-08-03
WO2006080842A3 (en) 2006-09-14
WO2006080842A2 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
CR9269A (es) Vacunas orales para peces
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CO2018005229A2 (es) Vacuna de virus sincitial respiratorio
CY1123450T1 (el) Μεθοδος καθαρισμου συζευγματων βασει il-15/il-15ra
CY1117563T1 (el) Αντισωματα κατα her3 και χρησεις αυτων
CY1121934T1 (el) Αντισωματα anti-fcrn
CY1124979T1 (el) Κατασκευασματα πρωτεϊνης uspa2 και χρησεις αυτων
CY1120319T1 (el) Πρωτεϊνες συντηξης και εμβολια συνδυασμου που περιλαμβανουν haemophilus influenzae πρωτεϊνη ε και πιλινη α
CO6491045A2 (es) Composiciones de proteina f de virus sincitial respiratorio (rsv) y metodos para producir las mismas
AR088693A1 (es) Anticuerpos especificos para trop-2 y sus usos
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
EA201070200A1 (ru) Композиции, содержащие пневмококковые антигены
CY1115030T1 (el) Διειδικα αντι-vegf/αντι-ang-2 αντισωματα
AR082149A1 (es) Anticuerpos contra el virus sincicial respiratorio (rsv) humano y metodos para su uso
BRPI0621181A8 (pt) Substâncias imunogênicas que compreendem um adjuvante a base de ácido poliinosínico - ácido policitidílico
AR086871A1 (es) Composicion descongelante, proceso de preparacion, conjunto de partes y uso
PE20212265A1 (es) Bioconjugados de antigenos-polisacaridos de e. coli, metodos de produccion y metodos de utilizacion de los mismos
AR103544A1 (es) FORMULACIONES FARMACÉUTICAS PARA ANTICUERPOS ANTI-TNF-a
MX2008013619A (es) Aumento del titulo para vacunacion en animales.
UY37279A (es) Anticuerpos tgf-beta y fragmentos de unión de los mismos
EA201891124A3 (ru) Новые мукозные адъюванты и системы доставки
WO2014150822A3 (en) Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
BRPI0915076A2 (pt) composições de vacina, composição imunogênica, método para expressão dos antígenos quiméricos de hpv-hbsag supramencionados, composição farmacêutica, método para ocasionar resposta de anticorpo protetor para composição antigênica e/ou resposta de célula t citotóxica, uso das formulações antigênicas supramencionadas.
MX2023004834A (es) Formulaciones de vacunas de glicoconjugados de expec.
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)